drugset / Trial / NCT00054522

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy

NCT00054522 ↗

Phase 2 Completed 15 enrolled Roswell Park Cancer Institute
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Calcitriol may help tumor cells develop into normal cells. Dexamethasone may increase the effectiveness of calcitriol by making tumor cells more sensitive to the drug. PURPOSE: Phase II trial to study the effectiveness of combining calcitriol with dexamethasone in treating patients with prostate cancer who have undergone surgery or radiation therapy.

Timeline

Start
2002-04
Primary completion
2006-01
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Oral

Indications